AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Canine Erythropoietin Gene and Recombinant Protein

Detailed Technology Description

Anemia, a condition in which too few red blood cells (RBCs) are in circulation is characterized by clinical signs of weakness, lethargy and inappetance and can be divided into two forms - regenerative and nonregenerative

Others

MacLeod JN et al. Expression and bioactivity of recombinant canine erythropoietin. Am J Vet Res. 1998 Sep;59(9):1144-8.

http://www.ncbi.nlm.nih.gov/pubmed/9736393?ordinalpos=18&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Randolph JE et al. Clinical efficacy and safety of recombinant canine erythropoietin in dogs with anemia of chronic renal failure and dogs with recombinant human erythropoietin-induced red cell aplasia. J Vet Intern Med. 2004 Jan-Feb;18(1):81-91.

http://www.ncbi.nlm.nih.gov/pubmed/14765736?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Randolph JF et al. Comparison of biological activity and safety of recombinant canine erythropoietin with that of recombinant human erythropoietin in clinically normal dogs. Am J Vet Res. 1999 May;60(5):636-42.

http://www.ncbi.nlm.nih.gov/pubmed/10328437?ordinalpos=17&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Country/Region

USA

For more information, please click Here